Kenya Bone Disease Market Analysis


  • Type: Therapeutics Area
  • Published : June 2021
  • Region: Africa
  • Country: Kenya
  • Report ID : 4815

  • Format: PPT, PDF

Kenya Bone Diseases Drug Market: Segmented by Disease types (Osteoporosis, Osteomalacia, Paget’s Disease, Osteogenesis Imperfecta, Bone cancer, Rickets and Other Applications), Drug Class (Bisphosphonates, Hormone Therapy, Monoclonal Antibodies, Calcium and Vitamin D supplements and Other Drug Classes), Route of Administration (Oral, Injectable route) and Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) – Growth, Trends, and Forecasts (2019 – 2028)

SKU: 4815 Categories: ,

Report Overview

The Bone diseases Drug market size in Kenya stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

The most common disease affecting bones is Osteoporosis. It is a Bone-Mineral Density (BMD) disease in which the bones become weak and brittle due to loss of bone density which increases the risk of fractures. The World Health Organization (WHO) operationally defines osteoporosis as a Bone Mineral Density (BMD) that falls 2.5 Standard Deviations (SD) below the mean for young healthy adults. Osteoporosis is common among females above age 50 due to menopause. A positive association between osteoporosis and advancing age, poverty, illiteracy, and being underweight was found. In Kenya, the prevalence of osteoporosis stands at 24.3%. It is often overlooked and undertreated because it is clinically silent unless it presents with a fracture. Osteoporosis is not regarded as a health priority in Kenya. Despite ample sunshine, Africa registers the highest rates of rickets worldwide. Low levels of vitamin D cause Osteomalacia in adults and Rickets in children.

Market Drivers

The market is majorly driven due to the rising prevalence of bone diseases in urban population caused due to adoption of modern lifestyles, physical inactivity, dietary changes, and hormonal changes due to ageing. A Kenyan study, in a hospital-based setting reported rates of osteopenia in pre- and post-menopausal women to be 20.5% and 32% respectively.

The increase in the prevalence of bone diseases is also attributed to increased alcohol consumption and smoking, low levels of Vitamin D and underlying medical conditions like chronic kidney disease  (CKD). Osteoporosis is males is attributed to decline in the testosterone levels with ageing.

Over the past few decades, there has been increase in focus towards female health in the country that has led to increase in the awareness levels among women.

However, the side effects caused by the drugs is one of the restraining factors. Some of the drugs have been found to have carcinogenic effect.

Diagnosis is a challenge due to low index of suspicion and due to the limited number of DEXA machines in the country and Africa as a whole. Kenya has 2 DEXA machines that serve a population of 40 million and the greater East Africa region. This limits the growth of bone diseases Drug market.

1. Kenya Bone Diseases Drug Market Overview………………………………………….
A. Market Size
2. Market Growth Drivers……………………………………………………………..…
A. Rising Prevalence of Bone Diseases Among Urban Population
B. Increase in Focus Towards Female Health
C. Increase in the Risk Factors Associated with Bone Diseases
3. Major Bone Diseases…………………………………………………………………
A. Osteoporosis
B. Osteomalacia
C. Paget’s Disease
D. Osteogenesis Imperfecta
E. Bone Cancer
F. Rickets
G. Others
4. Bone Diseases Drug Market Segmentation………………………………………..
A. Drug Class
I. Monoclonal Antibodies
II. Bisphosphonates
III. Hormone Therapy
IV. Calcium and Vitamin Supplements
V. Others
B. Route of Administration
I. Oral
II. Injectable
C. Distribution Channels
I. Hospital Pharmacies
II. Retail Pharmacies
III. Online Pharmacies
IV. Others
5. Bone Diseases Major Products Market Share……………………………….…
A. Key Findings
B. Market Analysis, Insights and Forecast – By Drug Type
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………..
A. Merck & Co. Company overview, Product & Services, Strategies & Financials
B. Roche Company overview, Product & Services, Strategies & Financials
C. Novartis Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape…………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth………………………………………………………
A. New Trends and Development of Bone Diseases drug market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Disease Type:

On the basis of disease type, the bone diseases Drug market in Kenya can be segmented into Osteoporosis, Osteomalacia, Osteogenesis Imperfecta, Paget’s disease, bone cancer, Rickets and others.

Osteogenesis Imperfecta is a rare inherited bone disorder characterized by fragile bones that break easily. Paget’s Disease is also a rare disease that disrupts the replacement of old bone tissue with the new bone tissue.

By Drug Class:

On the basis of drug class, the bone diseases Drug market is segmented into Bisphosphonates, Hormone therapy, Monoclonal Antibodies, Vitamin D and Calcium Supplements and other drug classes.

Hormone therapy is further segmented into Oestrogen therapy and Parathyroid hormone therapy. Forteo and Tymlos are powerful drugs similar to parathyroid hormone. Romozumab (Evenity) is the newest bone-building medication to treat osteoporosis.

By Route of Administration:

On the basis of route of administration, bone diseases Drug market is segmented into oral drugs and injectable route.

Hormone therapy is administered by the injectable route.

By Distribution Channels:

On the basis of distribution channels, the market is segmented into hospital pharmacies, retail pharmacies, online and others.

 Major Players

Many new players are emerging in the Bone diseases Drug market, as a result of a number of growth opportunities. The market will be majorly run by some of the companies which are currently dominating the market like Merck & Co., Eli Lilly (Suisse) SA, Roche, Novartis International AG, Pfizer, Inc. and Novo Nordisk.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements